Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsInterest & Investment IncomeNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) Revenue (2020 - 2025)

Historic Revenue for Roivant Sciences (ROIV) over the last 6 years, with Q4 2025 value amounting to $2.0 million.

  • Roivant Sciences' Revenue fell 7783.32% to $2.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $5.7 million, marking a year-over-year decrease of 7328.12%. This contributed to the annual value of $29.1 million for FY2025, which is 1118.82% down from last year.
  • Roivant Sciences' Revenue amounted to $2.0 million in Q4 2025, which was down 7783.32% from $1.6 million recorded in Q3 2025.
  • Over the past 5 years, Roivant Sciences' Revenue peaked at $24.3 million during Q4 2021, and registered a low of $1.6 million during Q3 2025.
  • Its 5-year average for Revenue is $9.9 million, with a median of $8.0 million in 2024.
  • Its Revenue has fluctuated over the past 5 years, first soared by 95721.84% in 2021, then tumbled by 7783.32% in 2025.
  • Over the past 5 years, Roivant Sciences' Revenue (Quarter) stood at $24.3 million in 2021, then fell by 29.95% to $17.1 million in 2022, then fell by 8.74% to $15.6 million in 2023, then crashed by 42.05% to $9.0 million in 2024, then plummeted by 77.83% to $2.0 million in 2025.
  • Its Revenue was $2.0 million in Q4 2025, compared to $1.6 million in Q3 2025 and $2.2 million in Q2 2025.